News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

NICE has recommended moving Novartis’ Kisqali (ribociclib) from interim funding arrangements to regular NHS reimbursement for certain previously treated breast cancer patients. In the final ...

In May 2024, Google DeepMind released AlphaFold 3, a game changing protein folding model that predicts with 50% better ...

Ibrance failed the PALLAS trial as adjuvant treatment for early breast cancer, giving Verzenio its ... catch-up in the category with Novartis’ Kisqali (ribociclib), which got a green light ...

Drugs that act against this target include Ibrance (palbociclib) and Kisqali (ribociclib), both of which are given alongside hormone therapies. A third new target for breast cancer treatment is the ...

University of Zagreb researcher Beata Halassy treated her breast cancer with an unproven virus-based therapy using viruses ...

American Cancer Society research shows despite significant drops in the mortality rate, breast cancer incidence rates have ...

A calculated flaw in perfection. New research suggests that Renaissance master artist Michelangelo Buonarroti had etched a ...

SKOPJE – A bottleneck in health-care services is causing dangerous delays in the diagnosis and treatment of breast cancer in ...

Under this two-hit model, Brugge says, one normal copy of BRCA1 ought to be able to carry out DNA repair even when the other copy is inactivated by an inherited mutation. This means that a total loss ...

Yale study reveals cultural influences in breast cancer surgery decisions, focusing on challenges faced by women of color post-mastectomy.

Artificial intelligence successfully detected a woman's breast cancer - after a routine scan came back as "normal." Sheila Tooth, from Littlehampton, West Sussex, was initially given the all-clear ...